|
|
|
|
Deep sequencing analyses of minority baseline polymorphisms and persistence of emerging mutations in HCV genotype 1-infected patients treated with simeprevir
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Bart Fevery,1 Kim Thys,2 Veerle Van Eygen,1 Thierry Verbinnen,1 Elizabeth Van Rossem,2 Gaston Picchio,3 Sandra De Meyer,1 Oliver Lenz1
1Janssen Infectious Diseases, Beerse, Belgium; 2Janssen CREATE, Beerse, Belgium; 3Janssen Research & Development, LLC, Titusville, NJ, USA
|
|
|
|
|
|
|